Revelation Biosciences In...

NASDAQ: REVB · Real-Time Price · USD
2.57
-0.01 (-0.39%)
At close: Aug 15, 2025, 3:51 PM
2.60
1.33%
After-hours: Aug 15, 2025, 07:36 PM EDT

Revelation Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-15.04M -120.25K -10.83M -11.99M
Depreciation & Amortization
27.92K 25.05K 25.05K 16.78K
Stock-Based Compensation
168.85K 155.72K 301.12K 470.88K
Other Working Capital
-2.85M 232.47K -64.93K 625.86K
Other Non-Cash Items
-56.44K -8.33M 14.96K 52.38K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-3.42M 982.13K -730.97K 356.22K
Operating Cash Flow
-18.32M -7.29M -11.22M -11.09M
Capital Expenditures
-19.17K -4 -4 -131.96K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a 525.29K
Other Investing Acitivies
n/a 4.00 n/a -525.29K
Investing Cash Flow
-19.17K n/a n/a -131.96K
Debt Repayment
n/a n/a -796.88K n/a
Common Stock Repurchased
n/a -5K -7.65M n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 34.00 11.54M n/a
Financial Cash Flow
12.85M 14.03M 15.2M 8M
Net Cash Flow
-5.49M 6.74M 3.98M -3.22M
Free Cash Flow
-18.34M -7.29M -11.22M -11.22M